Valneva SE announced its participation in the 26th World Vaccine Congress in Washington D.C. from March 31 to April 2, 2026, with presentations and a panel on its chikungunya vaccine IXCHIQ® and a booth presence. This includes updates on a pilot vaccination campaign in Brazil with Instituto Butantan, where over 12,000 people have been vaccinated for post-marketing studies.
Key takeaways
Valneva participating in 26th World Vaccine Congress, March 31-April 2, 2026, Walter E. convention center, Washington D.C.
Susanne Eder-Lingelbach presents on April 1, 2026 at 9:40 am EST: Vaccine Development updates for chikungunya – Phase IV and real-world evidence studies.
Dr. Juan Carlos Jaramillo on panel April 1, 2026 at 9:55 am EST: chikungunya and mosquito-borne vaccines.
Pilot vaccination campaign launched with Instituto Butantan in Brazil using IXCHIQ®; over 12,000 vaccinated for effectiveness and safety evaluation.
Valneva booth #538 at exhibition area for partner meetings.